Best Healthcare Companies in Woburn, United States
The 39 best Healthcare companies in Woburn, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Viva Tides.
Ranked: Best Healthcare companies in Woburn
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Viva Tides Manufacturer of oligonucleotides therapeutics | $54M | 4 mo ago | Series A | Keming Zhou Founder & CEO | 2025 | — | — | — |
| 2 | Ethos Vet Health Provider of veterinary hospitals and healthcare services | $21M | 126 mo ago | Acquired | — | 2015 | WordPressApple iCloud MailMicrosoft 365+22 | — | — |
| 3 | Azurity Pharmaceuticals Manufacturer of generic drugs | $20M | 140 mo ago | Early Stage | Indu Muni President & CEO | 1999 | WordPressApple iCloud MailMicrosoft 365+25 | — | — |
| 4 | Continuus Pharma Innovative pharmaceutical manufacturing solutions using integrated continuous manufacturing (ICM) | $8M | 84 mo ago | Series B | Bayan Takizawa Co-Founder | 2012 | WordPressMySQLPHP+20 | — | — |
| 5 | Javelin Biotech CRO focused on providing drug discovery and preclinical study services | $3M | 36 mo ago | Funding Raised | Kevin O'Handley Co-Founder and COO | 2019 | Cart FunctionalitySquarespace CommerceSquarespace+12 | — | — |
| 6 | Comera Manufacturer of medical devices | $2M | 32 mo ago | Series A | Zach Jonasson Co-Founder | 2014 | — | — | — |
| 7 | Organix Custom synthesis, research chemicals, and CRO services for complex chemistry challenges | $763K | 179 mo ago | Acquired | — | 1986 | Cart FunctionalitySquarespace CommerceSquarespace+17 | 68 patents Agricultural bioactive chemicals, nutrient‑rich biodegradable films, and VMAT‑targeting neuropharmaceuticals. | — |
| 8 | SPO Global Limited information available | $688K | 159 mo ago | Public | Max Boscaino CEO | 1981 | — | — | — |
Top 8 Healthcare companies in Woburn
#1
Series A · Woburn, Massachusetts · founded 2025$54Mraised▾
Manufacturer of oligonucleotides therapeutics. It specializing in developing extrahepatic RNA-targeting therapeutics. The company aims to overcome traditional limitations by delivering siRNA and antisense oligonucleotides to tissues beyond the liver, such as muscles and the nervous system, for treating chronic diseases.
- Apr 2026Series A$54M
#2
Funding Raised · Woburn, Massachusetts · founded 2019 · 11 employees$2.6Mraised▾
CRO focused on providing drug discovery and preclinical study services
- Aug 2023Grant (prize money)$2M
- Aug 2022Grant (prize money)$314.8K
- Sep 2021Grant (prize money)$254.1K
#3
Series A · Woburn, Massachusetts · founded 2014 · 16 employees$1.7Mraised▾
Manufacturer of medical devices
- Dec 2023Series A$1.5M
- Aug 2023Seed$238.3K
#4
Acquired · Woburn, Massachusetts · founded 2015 · 601 employees$21Mraised▾
Ethos provides veterinary hospitals and healthcare services. The company offers veterinary care and medicine for both pets and their owners.
- Feb 2016Conventional Debt$21M
#5
Early Stage · Woburn, Massachusetts · founded 1999 · 402 employees$20Mraised▾
Manufacturer of generic drugs
- Dec 2014Unattributed$20M
#6
Series B · Woburn, Massachusetts · founded 2012 · 47 employees$7.7Mraised▾
Innovative pharmaceutical manufacturing solutions using integrated continuous manufacturing (ICM). They specialize in end-to-end integrated continuous manufacturing, applying novel process technologies for rapid pharmaceutical production with reduced costs and improved quality assurance. Their mission is to produce high-quality drugs, delivered more effectively and at a lower cost, transforming the pharmaceutical manufacturing industry from outdated batch systems to state-of-the-art continuous processes. Leveraging a novel continuous manufacturing platform, they aim to improve affordability and accessibility of pharmaceuticals globally. They offer targeted solutions, from single continuous unit operation applications to end-to-end processes, addressing specific client needs with a modular and flexible approach. They collaborate with government agencies and leading global pharmaceutical companies, offering innovative technology with potential impact on the pharmaceutical industry. They are also establishing its own generic business.
- Aug 2019Series B$5M
- Mar 2016Grant (prize money)$1.3M
- Feb 2016Grant (prize money)$1.3M
- Jan 2015Grant (prize money)$150K
#7
Acquired · Woburn, Massachusetts · founded 1986 · 44 employees$763.3Kraised▾
Custom synthesis, research chemicals, and CRO services for complex chemistry challenges. The company specializes in delivering solutions for organic and medicinal chemistry needs. They offer custom synthesis, analytical services, and contract R&D, with expertise in lipids, oligonucleotides, and polymer chemistry. Their services support breakthroughs across biotech, pharma, and materials science. They provide custom polymers and polymer nanoparticles for drug delivery, biomaterials, and advanced materials science. The company offers high-precision testing and characterization for quality control and compliance, process development, and medicinal chemistry services. They provide tailored compound synthesis to accelerate discovery and development, offering both fee-for-service and full-time equivalent research models to fit project needs.
- Sep 2011Grant (prize money)—
- Sep 2011Grant (prize money)$681.3K
- May 2010Grant (prize money)$82K
#8
Public · Woburn, Massachusetts · founded 1981 · 7 employees$688.2Kraised▾
Limited information available
- May 2013Post IPO$250K
- Jul 2010Post IPO$438.2K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.